Do indicators for the proportion of pharmaceutical spending alleviate the burden of medical expenditure? Evidence from provincial panel-data in China, 2010-2019-Reference-Cited by-同舟云学术

Do indicators for the proportion of pharmaceutical spending alleviate the burden of medical expenditure? Evidence from provincial panel-data in China, 2010-2019

Published:2021-04-21 Issue: Volume: Page:1-9
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Yang Tianan¹²,Deng Wenhao¹²,Zhao Weigang¹²³,Liu Jiahao¹²,Deng Jianwei¹²

Affiliation:

1. School of Management and Economics, Beijing Institute of Technology, Beijing, China

2. Sustainable Development Research Institute for Economy and Society of Beijing, Beijing Institute of Technology, Beijing, China

3. Center for Energy and Environmental Policy Research, Beijing Institute of Technology, Beijing, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1917999

Reference31 articles.

1. World Health Organization. Measuring medicine prices, availability, affordability and price components 2nd edition. 2008. [cited 2021 Jan 10]. Available from: http://www.haiweb.org/medicineprices/manual/documents.html.

2. The impact of China’s national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces

3. The effects of rebate contracts on the health care system

4. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage

5. Organization for Economic Co-operation and Development. Pharmaceutical spending (indicator). 2020. [cited 2021 Jan 10]. Available from:https://data.oecd.org/healthres/pharmaceutical-spending.htm#indicator-chart